Extracts of fetal calf brain cause a 3-to 5-fold increase in acetylcholine receptors (AcChoR) on cultured myogenic L5 cells. Purification of the substance causing the major portion of this receptor increase has been completed. Ultraviolet spectral characteristics, nuclear magnetic resonance, mass spectra, and AcChoR induction by the active factor are the same as those of commercially available ascorbic acid. The biological activity of ascorbic acid is not mimicked by reducing agents with or without sullhydryl groups. Compounds related to ascorbic acid were tested for their ability to induce AcChoR increases on L5 cells. D-Isoascorbic acid is the only substance with identical biological activity to ascorbic acid. Dehydroascorbic acid and ascorbic acid 2-0-sulfate also induce AcChoR increases but with lower specific activity. These data show that ascorbic acid can play a role in regulating AcChoR expression in myogenic tissue, and the presence of ascorbic acid in the purified fraction from fetal calf brain accounts for its ability to increase AcChoR in L5 cells.
A major effect of coculturing rat spinal cord explants with L6 myogenic cells is an increase in the average site density of acetylcholine receptors (AcChoR) on the differentiated myotubes. The increase in receptor site density on myotubes adjacent to the explant is greater than that occurring on myotubes a few millimeters away. This graded distribution has been taken as an indication of the release, from the explant, of a diffusible substance causing the receptor increase (1) . Similar results have been obtained in cocultures derived from chicken embryos (2) . In addition to the increase in receptor site density, there is also an increase in the number of AcChoR clusters in these cultures (1, 2) .
Since it appears that the effects on AcChoR clustering and site density may be caused by different substances (3) , in the present study we directed our attention toward the overall increase in AcChoR. This effect is of interest because changes in average AcChoR site density also occur during muscle development in vivo (4) . Shortly after the fusion of mononucleated myoblasts, AcChoR levels increase dramatically (5, 6) , and then decrease following innervation (7, 8) . Denervation of adult skeletal muscle results in a return to preinnervation site densities (9) (10) (11) . The purification and identification of a soluble factor capable of inducing AcChoR site density increases offers an approach to the study of in vivo AcChoR site density regulation and, possibly, the control of AcChoR synthesis as well.
The effects of nerve explants on AcChoR site density in myogenic tissue can be mimicked by soluble extracts of fetal rat, chicken, or calf brain (1, (12) (13) (14) . We have used the increase in total AcChoR on L5 cells caused by fetal calf brain extracts (14) as an assay for the purification of the active factor. The L5 (46) cell line has similar characteristics to the L6 cell line isolated by Yaffe (15) . We report here the identification of the material from fetal calf brain extracts, which is largely responsible for causing the increase in AcChoR, as L-ascorbic acid. Since others have shown that L-ascorbic acid accumulates in skeletal muscle following denervation, we suggest that ascorbic acid may be involved in regulating AcChoR synthesis in vivo.
MATERIALS AND METHODS
Cell Culture. L5 cells were suspended in 0.25% "pancreatin" in Dulbecco's modified Eagle's medium (DME medium). Cells were diluted to 5 x 104 cells per ml in DME medium containing 10% heat-inactivated fetal calf serum, and 0.5 ml was plated into individual wells of Falcon multiwell tissue culture plates (2.0 cm2 = growth area). Fractions for assay were sterilized through 0.45-gm filters (Gelman) and added to triplicate wells. One dose of the sample was added per day for 2 consecutive days beginning either day 4 or 5 after plating. Cultures were assayed for a-bungarotoxin (a-BGT) binding on day 3 after the first dose. This addition schedule was previously determined to be optimal in eliciting the AcChoR response in L5 cells (14) . Fractions containing 0.1% 2-mercaptoethanol were always lyophilized prior to addition to cell cultures in order to decrease 2-mercaptoethanol concentration. Lyophilized fractions were resuspended in H20 or H20 containing fresh 0.05% 2-mercaptoethanol prior to assay. Volumes of fresh 0.05% 2-mercaptoethanol that were less than 15 ,ul did not affect cell cultures or the AcChoR response.
Binding of Iodinated a-BGT. a-BGT iodinated with 1251 (125I-a-BGT) was prepared in our laboratory (16) and used to label cultures. Specific activities from 15 to 300 Ci/mmol were used (1 Ci = 37 GBq). Cells were labeled for 30 min with 20 nM 1251I-a-BGT in Tyrode's buffer containing bovine serum albumin at 2 mg/ml (buffer A). The labeled a-BGT was aspirated off, and the cells were washed in buffer A for a minimum of five 2-ml rinses over the course of 30 min. The buffer A was then aspirated, and the cells were dissolved in 1.5 ml of 2.0 M NaOH overnight. The 22 ,000 x g for 40 min. The supernate was lyophilized, and the lyophilized material was resuspended in H20 containing 0.01% 2-mercaptoethanol in one-quarter of the supernate volume and was centrifuged at 100,000 x g for 1 hr. The supernate was decanted and lyophilized. The equivalent of 10 ml of this supernate was resuspended in 6 ml of 2.0 mM NH4OAc (pH 4.0), centrifuged at 10,000 x g for 15 min, and the supernate was loaded onto a 418-ml (2.6 x 78.8 cm; 60 ml/hr) Sephadex G-15 column in the same buffer. All column buffers contained 0.1% 2-mercaptoethanol and were flushed with N2 for at least 1 hr prior to fractionation. Active fractions from all columns were flushed with N2 for at least 10 min prior to lyophilization. Activity was eluted as a single peak at partition coefficient Kavg = 0.54. The active fractions were pooled, lyophilized, resuspended in 3 ml of 0.05 M NH4OAc (pH 6.0), and loaded onto a 44-ml (1.5 x 25 cm) Bio-Rad AG1-X8 anion-exchange column. The activity was step-eluted from the column in 1.4 M NH4OAc (pH 6.0) at 32 ml/hr. The activity was in the major UV absorbing peak (265 nm). The peak fractions were pooled and lyophilized. This pooled fraction was loaded onto a 75-ml (2 x 24 cm) Sephadex G-10 column in 1.5 ml of running buffer [2.0 mM NH4OAc (pH 6.0); 30 ml/hr] and was eluted at Kavg = 0.28 as the first peak of a doublet. The active fractions were pooled and lyophilized. The lyophilized material was resuspended in 1.5 ml of 0.05 M NH4HCO3 (pH 8.7) and loaded onto a 37.6-ml (17.8 cm x 1.6 cm; 24 ml/hr) DEAE-Sephadex column equilibrated with the same buffer. One column volume of the running buffer was run prior to gradient elution (0.05-0.2 M; 300 ml) at 0.08 M NH4HCO3. The major UV absorbing peak was pooled, divided into aliquots, flushed with N2, and lyophilized.
Mass Spectrometry. Mass spectrometry was done at the Cornell University Chemistry Department facility. Side-byside derivatizations were carried out with 1 mg of L-ascorbic acid (ICN) in 0.3 ml of silylating mixture (Tri-Sil; Pierce) and =450 ,g of the purified fraction in 0.1 ml of the silylating mixture; 1.8 ,ul of each were injected into a Finnigan 3300 GC/mass spectrometer. GC stationary phase was 3% OV101 (Alltech), and the column temperature gradient was 80-2500C in 30 min. Samples were ionized by electron impact. (Spectra obtained with chemical ionization were identical for ascorbate and the purified fraction.) NMR Spectroscopy. 3H NMR spectra were obtained at 300
MHz with a Bruker WM-300 spectrometer at the Cornell University Department of Chemistry. Samples were =0.5 mg/ml of 2H20 (Aldrich). Data were obtained at 27°C in the Fourier transform mode by using a ca. 600 pulse width and a 2.7-sec relaxation time. Data manipulation included exponential multiplication of the free induction decay, which corresponded to 0.1 Hz of line-broadening after Fourier transformation. Spectra were referenced externally to 1 mg of sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) per ml of 2H20. Homonuclear decoupling experiments were performed in the usual manner.
Thin-Layer Chromatography. Chromatography was performed on silica gel (Merck) coated glass plates (-7 x 2 cm). The two solvent systems used were (i) 2- (Fig. 1) . This suggests that the purified fraction is structurally similar to ascorbic acid. Since functional groups such as 2-0-sulfate (18) can be displaced by derivatization and side chain isomers might not be obvious in the mass spectra, we used1H NMR spectroscopy to confirm the structure of the fraction. 1H NMR resonances in deuterium oxide were observed at 3.73, 4 .00, and (22) . The effect of ascorbic acid on a-BGT binding was tested in our assay system and appears to be the same as the purified fraction (Fig. 2) , inducing a maximal AcChoR increase of 248% 37% (SEM; n = 6). Estimates of the concentrations of the purified fraction using the ascorbic acid extinction coefficient led to close agreement in the dose-response curves of ascorbic acid and the purified fraction (Fig. 2) . From these data we calculate a yield of 100-300 pkg of ascorbate purified from 1.0 g of wet weight of fetal calf brain. At doses of ascorbic acid that induced a maximal AcChoR response, total protein levels in treated cultures were only 24% 2% (range; n = 4) greater than untreated controls. Under these same conditions, levels of the cytoplasmic enzyme creatine kinase remained unchanged. These results were essentially the same for unfractionated extract, the details of which will be published elsewhere. The late metal ions as well. It is possible that AcChoR increases induced by ascorbic acid could be a nonspecific response to its reducing properties. The specificity of the response was tested with a variety of reducing agents, chelators, iron compounds, and ascorbic acid analogues. The results of these experiments and the dose ranges tested are shown in Table  1 . Only three of these compounds induced any AcChoR response, and each of the active substances was an ascorbic acid derivative. The dose-response curves of the active substances are given in Fig. 3 . D-Isoascorbic acid, an ascorbic acid isomer, had biological activity identical to ascorbic acid. Dehydroascorbic acid and ascorbic acid 2-0-sulfate had specific activities 1/5th to 1/10th that of ascorbic acid. When EDTA was added simultaneously with a dose of ascorbic acid that elicits a maximal AcChoR response, the ascorbic acid effect was unchanged. It is concluded that the effect of ascorbic acid is not likely to be a nonspecific result of its properties as a chelator or reducing agent. DISCUSSION L5 cells and other myogenic cells divide and differentiate in the absence of exogenously applied ascorbic acid. We have demonstrated that serum level concentrations (23) of ascorbic acid (10 Ag/ml) in the growth medium can significantly increase AcChoR levels on L5 cells in vitro. This induction of AcChoR by ascorbic acid is a relatively specific effect. If it were due to a generalized growth, fusion, or survival effect of ascorbic acid on L5 cells, then total protein and the activity of the muscle-specific cytoplasmic enzyme creatine kinase should increase similarly instead of remaining virtually unaffected.
Ascorbic acid is present at 100-500 pug/g of brain tissue
(wet weight) in adult vertebrates (23) . It is believed that in fetal and newborn animals the levels are somewhat higher (24) (25) (26) . Thus, aqueous brain extracts contain sufficient amounts of ascorbic acid to account for their ability to induce AcChoR accumulation in vitro. Although the differences in the magnitudes of the responses induced by both the purified fraction and ascorbic acid are not statistically different from unfractionated extracts, it remains possible that ascorbic acid does not account for all of the activity in brain extracts. Because the means of both responses are substantially lower than that of the unfractionated extract and there is a fair amount of variability from experiment to experiment (for an example of this variation, see the percentage increases in the legend of Fig. 2) , such a conclusion must await direct tests involving selective depletion of ascorbic acid from unfractionated extracts. Using extraction procedures identical to those used for fe- Fig. 2 ; 100 nmol of ascorbic acid is equivalent to 17.6 pg.) tal brain, we have assayed homogenates of fetal calf liver, spleen, and kidney (unpublished results). No ability to induce AcChoR accumulation was detected in any of these tissues. Others have found similar tissue specificity for AcChoR-inducing activity (1, 12) . Ascorbic acid is, however, present in the liver and spleen at levels equals to or exceeding those of brain (23) , and extracts of these tissues might be expected to induce ascorbic acid-like effects. It is significant that others have reported similar differences between liver extracts and ascorbic acid when added to myogenic cells in vitro. Kalcheim et al. (27) have found that, although both ascorbic acid and fetal brain extracts induce a doubling of the number of AcChoR clusters on myotubes, liver extracts do not show this effect. Taken together, these findings suggest the presence of substances in the crude extracts that affect the stability, extraction, or biological activity of ascorbate. Such substances may be differentially distributed among the tissues we have studied so that the biological activity merely appears to be brain specific.
Our initial attempts at purification of the AcChoR-inducing activity from fetal calf brain by a number of methods led to low and inconsistent recovery of activity. We attempted to further purify some of these low-activity fractions with poor results. This result is explained by the fact that ascorbic acid is susceptible to rapid oxidation. The rate is inversely related to concentration with a t ½ , , at 0.6 mM = <4 hr (28).
When 0.1% 2-mercaptoethanol, a reducing agent, was introduced into all steps of the purification, activity comparable to that of the crude extract was consistently recovered as a single peak. Under these conditions we observed no other fractions with comparable activity.
Buc-Caron et al. (29) , using substantially different assay conditions with reducing agents only in their extraction buffer, reported AcChoR synthesis-promoting activity from embryonic chicken brain is likely to be due to one or more small peptides. This activity was retained on reversed-phase HPLC in trifluoroacetic acid and was eluted in acetonitrile. Neither ascorbic acid (30) nor our activity was appreciably retained on reversed-phase HPLC in the absence of ion-pairing agents. Thus, it is unlikely that ascorbic acid would be present in the partially purified fraction described by BucCaron et al. The AcChoR increase is specific to ascorbic acid and some closely related analogues. None of the reducing agents tested affected AcChoR levels. These results imply that the biological activity of ascorbic acid is not likely to be the result of the reduction of some medium component, such as a specific metal ion. Furthermore, addition of reduced iron resulted in no AcChoR increase. Ascorbic acid also can chelate ions such as Ca2' and Mg2+ (28) . EDTA chelates these cations as well but did not induce an AcChoR increase, indicating that the removal of an ion by chelation does not explain the biological activity of ascorbic acid.
Some of the other compounds tested were chosen because they had more specific similarities to ascorbic acid. Like ascorbic acid, dihydroxyfumaric acid is a nonsulfhydryl reducing agent, and has reactivity similar to that of ascorbic acid in a number of other chemical reactions (31) , but it did not induce an increase in AcChoR. L-Gulono-y-lactone is a structural analogue to ascorbic acid lacking only the ring double bond. Likewise, it had no activity in the AcChoR assay. The compounds that did show biological activity were dehydroascorbic acid, ascorbic acid 2-0-sulfate, and Disoascorbic acid. Each of these molecules has been shown by others to have biological activity equivalent to ascorbic acid, at least in some systems (32) (33) (34) . Although D-isoascorbic acid does not compete well with L-ascorbic acid for tissue uptake in vitro (23) , it has been shown to be an effective antiscorbutic agent on its own (33) . D-Isoascorbic acid also mimics the biological activity of ascorbic acid on fibroblasts in vitro (34) . The antiscorbutic effects of ascorbic acid 2-0-sulfate and dehydroascorbic acid have been attributed to the existence of cellular systems or enzymes capable of converting them to ascorbic acid (31) (32) (33) (35) (36) (37) . Thus, the activity of these compounds in our assay system is consistent with ascorbic acid being a specific effector of AcChoR increases on L5 cells.
The molecular mechanism by which ascorbic acid affects the accumulation of AcChoR is not known. Ascorbic acid could have a direct effect on any of a number of steps in the AcChoR biosynthetic pathway. These include effects on synthesis, degradation, processing, packaging, or transport. Alternatively, ascorbic acid may act indirectly, affecting other cellular processes, which in turn affect AcChoR. One such well-known ascorbate-sensitive process is collagen synthesis. Ascorbate is a cofactor in the post-translational hydroxylation of collagen (38) . Kalcheim et al. (27) have reported that, in rat primary muscle cell cultures, along with the induction of AcChoR clustering, ascorbic acid stimulates the synthesis of collagen. It is possible that the induction of AcChoR accumulation that we have observed was a secondary result of a stimulation of collagen synthesis or hydroxylation. Other indirect mechanisms aside from collagen effects are also possible because ascorbate is involved in a number of additional intracellular processes including lipid metabolism (39), peptide amidation (40) , and neurotransmitter synthesis (41, 42) . Ascorbic acid also has been implicated in specific muscle metabolic states (43) and inhibits calcium uptake by purified mitochondria (44) .
Ascorbic acid levels in skeletal muscle tissue in vivo are generally quite low [<50 pkg/gm of tissue (wet weight) (23)].
In rat skeletal muscle, ascorbic acid levels have been shown Proc. NatL Acad Sci. USA 82 (1985) to increase by 25% within the first 36 hr after denervation, leading to a doubling of ascorbic acid levels by day 5 (45) . Similar results have been obtained in frogs (19) and in guinea pigs (unpublished results). This change occurs concomitantly with a dramatic increase in AcChoR synthesis (9, 10) . In view of these observations, our results suggest ascorbic acid uptake may possibly be a causative agent in denervation-induced AcChoR synthesis in skeletal muscle.
